Director of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Baker Bros. Advisors Lp, buys 424,000 shares worth $6,466,000
According to Neoleukin Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 23 07:31 PM, company Director, Baker Bros. Advisors Lp disclosed buying 424,000 shares at a cost of $15.25. At the time of this transaction (Jul 07), this trade was worth $6,466,000 in total. As of Jul 07, Baker Bros. Advisors Lp now owns 3,501,691 shares in total worth about $37,713,212.07.
For the last few recent trades made by Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Director, Baker Bros. Advisors Lp, we have the following information:
- SEC Form 4 filing: Dec 20: Bought 3,017,542 shares at the rate of $8.40 per share. Total worth of this trade was $25,347,353. Total number of shares owned as of Dec 20 were 12,872,664
Posted by
George Daniels
on Thursday December 24 2020, 10:12 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
